BlackRock Institutional Trust’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$29.3M	Sell	1,755,099 -79,760	-4%	-$1.44M	﹤0.01%	1687
2016 Q3	$37.8M	Buy	1,834,859 +1,568	+0.1%	+$39.8K	0.01%	1463
2016 Q2	$56.1M	Sell	1,833,291 -32,139	-2%	-$1.12M	0.01%	1167
2016 Q1	$69.8M	Buy	1,865,430 +121,266	+7%	+$4.57M	0.01%	1033
2015 Q4	$75.3M	Buy	1,744,164 +70,504	+4%	+$2.98M	0.01%	1000
2015 Q3	$62.7M	Sell	1,673,660 -57,307	-3%	-$2.03M	0.01%	1106
2015 Q2	$58.8M	Sell	1,730,967 -142,168	-8%	-$4.83M	0.01%	1208
2015 Q1	$66.3M	Sell	1,873,135 -38,974	-2%	-$1.39M	0.01%	1156
2014 Q4	$65.1M	Buy	1,912,109 +48,254	+3%	+$1.71M	0.01%	1122
2014 Q3	$71.9M	Sell	1,863,855 -8,577	-0.5%	-$320K	0.01%	1038
2014 Q2	$72.9M	Sell	1,872,432 -14,529	-0.8%	-$541K	0.01%	1071
2014 Q1	$64.5M	Sell	1,886,961 -280,729	-13%	-$8.7M	0.01%	1126
2013 Q4	$45.5M	Buy	2,167,690 +172,634	+9%	+$4.37M	0.01%	1328
2013 Q3	$46.9M	Sell	1,995,056 -95,165	-5%	-$2.7M	0.01%	1244
2013 Q2	$56.2M	Buy	+2,090,221	New	+$60.6M	0.01%	1076